Products for Research Use Only
RegisterLogin

(S) -Bleximenib

CAT: 0804-HY-155797-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-155797-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
(S) -Bleximenib (Compound 28) ((S) -JNJ-75276617) is an isoform of Bleximenib. (S) -Bleximenib shows an IC50 greater than 1 μM in the MEIS1 mRNA expression assay. (S) -Bleximenib can be used in the research of acute myeloid leukemia[1].
CAS Number
2654081-27-1
Product Name Alternative
(S) -JNJ-75276617; (S) -Menin-MLL inhibitor 24
UNSPSC
12352005
Target
Drug Isomer; HOXA
Related Pathways
Cell Cycle/DNA Damage; Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
96.0600
Smiles
COCCN(C)CCC[C@H](N1CC2(C1)CN(C3=NC=NN=C3OC4=C(C=C(C=C4)F)C(N(CC)C(C)C)=O)CC2)C(C)C
Molecular Formula
C32H50FN7O3
Molecular Weight
599.78
References & Citations
[1]Wei, et al. Substituted straight chain spiro derivatives. WO2021121327A1. WIPO (PCT) . 2020-12-17.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-148669-01Bleximenib
HY-148669A-01Bleximenib (oxalate)
HY-125845B(S, S, S) -AHPC
HY-120217A(S, S, S) -VH032
HY-172298(R, S, S, S) -Orlistat
HY-112078B(S, S, S) -AHPC-Me
HY-123109A-01(S, S, S) -AHPC-Boc
HY-125845A-01(S, S, S) -AHPC (hydrochloride)
HY-78931B-01(S, S, S, S, R) -Boc-Dap-NE
HY-130671B(S, S) -DPPG

Alternative Products

CatalogName
GTR19277529-01Bleximenib
MBS5819820Bleximenib oxalate
GTR19274481-01(S) -Bleximenib
A24337-100Bleximenib (JNJ-75276617) 100mg
A24337-10Bleximenib (JNJ-75276617) 10mg
A24337-50Bleximenib (JNJ-75276617) 50mg
A24337-5Bleximenib (JNJ-75276617) 5mg
A24334-50Bleximenib oxalate (JNJ-75276617 oxalate) 50mg
A24334-5Bleximenib oxalate (JNJ-75276617 oxalate) 5mg
A24334-1Bleximenib oxalate (JNJ-75276617 oxalate) 1mg

Popular Products